Domain Therapeutics Doses First Patients in Phase I / II Trial of DT-7012 Targeting CCR8 in Solid Tumors
Article Date
October 28, 2025
This article is featured on another website.
Go to article
January 26, 2026
Understanding the US FDA’s Special Designations and Approval Pathways
Recognizing the challenges of drug development, the US FDA has established several special designations and…
January 26, 2026
Understanding the US FDA’s Special Designations and Approval Pathways
Recognizing the challenges of drug development, the US FDA has established several special designations and…
January 29, 2026
Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company
This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…
January 29, 2026
Rescuing a Rare Disease Trial: Accelerating MRCT RA Submissions for a Taiwan Biotech Company
This case study highlights HiRO's effective intervention in accelerating the regulatory submission process for a…